Search research articles
Contact Us
Filters
Showing results (21-30 of 140) with videos related to
Page
of 14
Sort By:
British Medical Journal
|
November 13, 1971
Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma
M R Robinson, B S Thomas
British Journal of Urology
|
December 1, 1981
Cardiovascular complications in the treatment of prostatic carcinoma
R W Glashan, M R Robinson
Actas Urologicas Espanolas
|
November 1, 1986
[Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period]
D P Daponte, I Stevens, M R Robinson
American Journal of Ophthalmology
|
May 15, 1989
Thrombocytopenia and vitreous hemorrhage complicating ganciclovir treatment
M R Robinson, C Teitelbaum, C Taylor-Findlay
European Urology
|
January 1, 1983
Prognostic significance of the symptoms associated with prostatic carcinoma
D Daponte, M R Robinson, P H Smith
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2000
Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor
M I Diamond, M R Robinson, K R Yamamoto
Cancer Treatment Reports
|
August 1, 1977
Melphalan in advanced prostatic cancer: a pilot study
A L Houghton, M R Robinson, P H Smith
British Journal of Urology
|
October 1, 1974
Adrenal suppression in the treatment of carcinoma of the prostate
M R Robinson, R J Shearer, J D Fergusson
European Journal of Cancer & Clinical Oncology
|
August 1, 1989
Standardized objective criteria of response--comments on 'Important Prognostic Value of Standardized Objective Criteria of Response in Stage D2 Prostatic Carcinoma' by Labrie F. et al
D Newling, M R Robinson, L Denis, et al.
Current Opinion in Ophthalmology
|
February 8, 2000
Ocular manifestations of HIV infection
M R Robinson, M L Ross, S M Whitcup
Page
of 14
Search research articles
Search
Showing results (21-30 of 140) with videos related to
Sort By:
Page
of 14
British Medical Journal
|
November 13, 1971
Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma
M R Robinson, B S Thomas
British Journal of Urology
|
December 1, 1981
Cardiovascular complications in the treatment of prostatic carcinoma
R W Glashan, M R Robinson
Actas Urologicas Espanolas
|
November 1, 1986
[Plasma changes caused by estrogens in the vascular risk of prostatic carcinoma over a 3-year period]
D P Daponte, I Stevens, M R Robinson
American Journal of Ophthalmology
|
May 15, 1989
Thrombocytopenia and vitreous hemorrhage complicating ganciclovir treatment
M R Robinson, C Teitelbaum, C Taylor-Findlay
European Urology
|
January 1, 1983
Prognostic significance of the symptoms associated with prostatic carcinoma
D Daponte, M R Robinson, P H Smith
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2000
Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor
M I Diamond, M R Robinson, K R Yamamoto
Cancer Treatment Reports
|
August 1, 1977
Melphalan in advanced prostatic cancer: a pilot study
A L Houghton, M R Robinson, P H Smith
British Journal of Urology
|
October 1, 1974
Adrenal suppression in the treatment of carcinoma of the prostate
M R Robinson, R J Shearer, J D Fergusson
European Journal of Cancer & Clinical Oncology
|
August 1, 1989
Standardized objective criteria of response--comments on 'Important Prognostic Value of Standardized Objective Criteria of Response in Stage D2 Prostatic Carcinoma' by Labrie F. et al
D Newling, M R Robinson, L Denis, et al.
Current Opinion in Ophthalmology
|
February 8, 2000
Ocular manifestations of HIV infection
M R Robinson, M L Ross, S M Whitcup
Page
of 14